Kinoshita Takao, Suzuki Manzo, Shimada Yoichi, Ogawa Ryo
Department of Anesthesiology, Nippon Medical School Second Hospital, 1-396 Kosugi-cho, Nakahara-ku, Kawasaki, Kanagawa 211-8533, Japan.
J Nippon Med Sch. 2004 Apr;71(2):92-8. doi: 10.1272/jnms.71.92.
Mild hypothermia is a common complication during spinal anesthesia and may induce a serious adverse outcome. We investigated the effect of low-dose ketamine infusion on the core temperature during spinal anesthesia sedated by propofol infusion. Twenty patients who were scheduled to undergo spinal anesthesia were assigned to one of two groups: after intrathecal injection of bupivacaine, patients who received infusion of ketamine (0.3 mg/kg/hr) and propofol (initial rate of 10 mg/kg/hr) (KP group), and patients who received infusion of placebo (saline) and propofol (initial rate of 10 mg/kg/hr) (P group). The rate of propofol administration was reduced as much as possible while maintaining sedation with an OAA/S score of 3 or below. The core temperature, forearm temperature, and fingertip temperature were recorded before spinal anesthesia, and just before (baseline) and 15, 30, 45, and 60 minutes after the start of propofol administration. The core temperature, reduction in core temperature from baseline (delta CT), and forearm-fingertip temperature gradient were compared between the two groups. In the P group, the core temperature linearly decreased over time. The core temperature at 30, 45, and 60 minutes was significantly higher in the KP group than in the P group (36.3 +/- 0.2 and 35.9 +/- 0.3, at 60 minutes, mean +/- SD, p < 0.05). The delta CT at 15, 30, 45, and 60 minutes was significantly smaller in the KP group than in the P group. There were no significant differences in the forearm-fingertip temperature gradient between the two groups over the study period. In conclusion, low-dose ketamine administration may confer thermoprotection during spinal anesthesia sedated by propofol.
轻度体温过低是脊髓麻醉期间的常见并发症,可能会导致严重不良后果。我们研究了小剂量氯胺酮输注对丙泊酚输注镇静下脊髓麻醉期间核心体温的影响。将20例计划接受脊髓麻醉的患者分为两组:鞘内注射布比卡因后,接受氯胺酮(0.3mg/kg/小时)和丙泊酚(初始速率10mg/kg/小时)输注的患者(KP组),以及接受安慰剂(生理盐水)和丙泊酚(初始速率10mg/kg/小时)输注的患者(P组)。在维持OAA/S评分3分或更低的镇静状态下,尽可能降低丙泊酚给药速率。记录脊髓麻醉前、丙泊酚给药开始前(基线)以及给药后15、30、45和60分钟时的核心体温、前臂温度和指尖温度。比较两组之间的核心体温、核心体温相对于基线的降低幅度(ΔCT)以及前臂-指尖温度梯度。在P组中,核心体温随时间呈线性下降。KP组在30、45和60分钟时的核心体温显著高于P组(60分钟时分别为36.3±0.2和35.9±0.3,均值±标准差,p<0.05)。KP组在15、30、45和60分钟时的ΔCT显著小于P组。在研究期间,两组之间的前臂-指尖温度梯度无显著差异。总之,小剂量氯胺酮给药可能在丙泊酚镇静的脊髓麻醉期间提供体温保护。